Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis

Documenti analoghi

• Treatment with cyclophosphamide i.v. pulse therapy is an option for effective treatment of skin fibrosis in patients with early systemic sclerosis
  di: Kersten, Brigit E, et al.
  Pubblicazione: (2020)
• Photoacoustic and high-frequency ultrasound imaging of systemic sclerosis patients
  di: Daoudi, Khalid, et al.
  Pubblicazione: (2021)
• Intravenous cyclophosphamide pulse therapy in interstitial lung disease associated with systemic sclerosis in a retrospective open-label study: influence of the extent of inflammation on pulmonary function
  di: van den Hombergh, W. M. T., et al.
  Pubblicazione: (2018)
• Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
  di: Wieneke M. T. van den Hombergh, et al.
  Pubblicazione: (2018-08-01)
• Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial
  di: van den Hombergh, Wieneke M. T., et al.
  Pubblicazione: (2018)